Emotional Prosody Treatment in Parkinson's

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Parkinson Disease
Interventions
BEHAVIORAL

Emotional prosodic treatment

The experimental treatment is consistent with the standard treatment in that it targets impairments in pitch/stress, loudness variability and control of speech rate, the core characteristics of prosodic insufficiency in PD (Darley, Aronson \& Brown, 1969). However, the experimental treatment provides an innovative and targeted emphasis on the emotional component of the disorder. The production of emotional intonation in an utterance requires varying combinations of pitch/stress, loudness, and rate. Participants will receive clinician feedback as well as auditory and visual feedback on accuracy via the VisiPitch display.

Trial Locations (1)

32608

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01956266 - Emotional Prosody Treatment in Parkinson's | Biotech Hunter | Biotech Hunter